This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: H. Lundbeck A/s. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Jesper Tungelund Larsen: Innovator in Injectable Pharmaceutical Compositions
Introduction
Jesper Tungelund Larsen is a notable inventor based in Valby, Denmark. He has made significant contributions to the field of pharmaceuticals, particularly in the development of injectable compositions. His work focuses on improving the efficacy and safety of drug formulations.
Latest Patents
Jesper Tungelund Larsen holds a patent for an injectable carbamazepine composition that is essentially free of 10-bromo-carbamazepine. This innovative pharmaceutical composition comprises carbamazepine and sulfobutylether-7-β-cyclodextrin. The patent also discloses methods for the manufacture of this composition and its application in treating various diseases.
Career Highlights
Jesper is currently employed at H. Lundbeck A/S, a leading global pharmaceutical company specializing in brain diseases. His role involves research and development, where he applies his expertise to create effective treatment options for patients.
Collaborations
One of his notable coworkers is Hans Petersen, with whom he collaborates on various projects within the company. Their combined efforts contribute to the advancement of innovative pharmaceutical solutions.
Conclusion
Jesper Tungelund Larsen's work in injectable pharmaceutical compositions exemplifies the importance of innovation in medicine. His contributions are paving the way for safer and more effective treatments for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile